...
首页> 外文期刊>BMJ Open >Is the HAS-BLED score useful in predicting post-extraction bleeding in patients taking warfarin? A retrospective cohort study
【24h】

Is the HAS-BLED score useful in predicting post-extraction bleeding in patients taking warfarin? A retrospective cohort study

机译:HAS-BLED评分对预测服用华法令的患者拔牙后出血是否有用?回顾性队列研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective Unexpected post-extraction bleeding is often experienced in clinical practice. Therefore, determining the risk of post-extraction bleeding in patients receiving anticoagulant therapy prior to surgery is beneficial. This study aimed to verify whether the HAS-BLED score was useful in predicting post-extraction bleeding in patients taking warfarin. Design Retrospective cohort study. Setting Department of Oral and Maxillofacial Surgery, Tokyo Women's Medical University. Participants Participants included 258 sequential cases (462 teeth) who had undergone tooth extraction between 1 January 2010 and 31 December 2012 while continuing warfarin therapy. Main outcome measure Post-extraction risk factors for bleeding. The following data were collected as the predicting variables for multivariate logistic analysis: the HAS-BLED score, extraction site, tooth type, stability of teeth, extraction procedure, prothrombin time-international normalised ratio value, platelet count and the use of concomitant antiplatelet agents. Results Post-extraction bleeding was noted in 21 (8.1%) of the 258 cases. Haemostasis was achieved with localised haemostatic procedures in all the cases of post-extraction bleeding. The HAS-BLED score was found to be insufficient in predicting post-extraction bleeding (area under the curve=0.548, p=0.867, multivariate analysis). The risk of post-extraction bleeding was approximately three times greater in patients taking concomitant oral antiplatelet agents (risk ratio=2.881, p=0.035, multivariate analysis). Conclusions The HAS-BLED score alone could not predict post-extraction bleeding. The concomitant use of oral antiplatelet agents was a risk factor for post-extraction bleeding. No episodes of post-extraction bleeding required more than local measures for haemostasis. However, because this was a retrospective study conducted at a single institution, large-scale prospective cohort studies, which include cases of outpatient tooth extraction, will be necessary in the future.
机译:目的在临床实践中经常会发生意外的拔牙后出血。因此,确定在手术前接受抗凝治疗的患者拔出后出血的风险是有益的。这项研究旨在验证HAS-BLED评分是否可用于预测服用华法林的患者拔牙后出血。设计回顾性队列研究。东京女子医科大学口腔颌面外科设置室。参与者包括258例连续病例(462颗牙齿),这些病例在2010年1月1日至2012年12月31日期间接受了华法林治疗的同时拔牙。主要结局指标拔牙后出血的危险因素。收集以下数据作为多变量逻辑分析的预测变量:HAS-BLED评分,拔牙部位,牙齿类型,牙齿稳定性,拔牙程序,凝血酶原时间-国际归一化比率值,血小板计数和使用抗血小板药。结果258例中有21例(8.1%)出现拔出后出血。在所有拔牙后出血病例中,均采用局部止血程序实现了止血。发现HAS-BLED得分不足以预测拔牙后出血(曲线下面积= 0.548,p = 0.867,多变量分析)。服用口服口服抗血小板药物的患者拔牙后出血的风险大约高三倍(风险比= 2.881,p = 0.035,多变量分析)。结论仅靠HAS-BLED评分不能预测拔牙后出血。口服抗血小板药的同时使用是拔牙后出血的危险因素。提取后出血的发作无须止血止血的局部措施。但是,由于这是在单个机构中进行的回顾性研究,因此将来有必要进行大规模的前瞻性队列研究,其中包括门诊拔牙病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号